Contravir Pharmaceuticals (CTRV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CTRV | AMGN | VRTX | GILD | BMY |
| Company | Contravir Pharmaceuticals | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 3.59 | 318.69 | 471.06 | 88.31 | 55.88 |
| High | 3.70 | 321.70 | 475.73 | 89.57 | 55.90 |
| Low | 3.53 | 316.91 | 463.14 | 88.19 | 54.20 |
| Last | 3.58 | 319.22 | 471.12 | 89.51 | 54.32 |
| Change | +0.02 | -0.94 | -4.86 | +0.69 | -1.45 |
| % Change | +0.56% | -0.29% | -1.02% | +0.78% | -2.60% |
| Volume | 139,100 | 1,826,700 | 1,352,700 | 6,485,800 | 12,894,800 |
| 20-Day Average Volume | 475,720 | 1,679,710 | 1,035,860 | 5,116,895 | 8,762,979 |
| Previous Close | 3.56 | 320.16 | 475.98 | 88.82 | 55.77 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.95 | 319.66 | 475.65 | 87.00 | 52.96 |
| 20-Day Raw Stochastic | 3.57% | 46.33% | 45.57% | 95.87% | 61.55% |
| 20-Day Relative Strength | 38.85% | 47.71% | 48.30% | 68.08% | 59.45% |
| Weighted Alpha | -86.50 | +16.17 | +22.10 | +20.53 | +10.38 |
| Today's Opinion | 100% Sell | 8% Buy | 24% Buy | 100% Buy | 88% Buy |
| Previous Opinion | 100% Sell | 24% Buy | 56% Buy | 100% Buy | 88% Buy |
| Last Month's Opinion | 100% Sell | 24% Buy | 8% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.01% since 07/15/19 | +0.71% since 10/25/24 | -1.38% since 10/25/24 | +0.57% since 10/25/24 | +4.62% since 10/25/24 |
| Low | 3.53 on 07/22/19 | 310.63 on 10/30/24 | 463.14 on 11/01/24 | 86.81 on 10/29/24 | 51.81 on 10/28/24 |
| High | 3.98 on 07/17/19 | 323.40 on 10/31/24 | 478.32 on 10/28/24 | 89.57 on 11/01/24 | 56.20 on 10/31/24 |
| 1-Month | |||||
| %Chg | -31.15% since 06/21/19 | -0.34% since 10/01/24 | +0.29% since 10/01/24 | +6.64% since 10/01/24 | +2.68% since 10/01/24 |
| Low | 3.52 on 07/05/19 | 310.63 on 10/30/24 | 447.70 on 10/07/24 | 83.10 on 10/02/24 | 51.31 on 10/15/24 |
| High | 5.20 on 06/24/19 | 329.17 on 10/11/24 | 499.09 on 10/17/24 | 89.74 on 10/25/24 | 56.20 on 10/31/24 |
| 3-Month | |||||
| %Chg | -75.65% since 04/22/19 | -4.86% since 08/01/24 | -6.85% since 08/01/24 | +17.02% since 08/01/24 | +12.77% since 08/01/24 |
| Low | 3.52 on 07/05/19 | 306.59 on 08/07/24 | 447.70 on 10/07/24 | 72.43 on 08/12/24 | 46.22 on 08/08/24 |
| High | 16.49 on 06/17/19 | 339.17 on 09/23/24 | 508.65 on 08/02/24 | 89.74 on 10/25/24 | 56.20 on 10/31/24 |
| 6-Month | |||||
| %Chg | -84.50% since 01/22/19 | +15.09% since 05/01/24 | +17.15% since 05/01/24 | +36.64% since 05/01/24 | +22.87% since 05/01/24 |
| Low | 3.52 on 07/05/19 | 274.90 on 05/02/24 | 394.03 on 05/07/24 | 62.07 on 05/31/24 | 39.35 on 07/05/24 |
| High | 25.20 on 03/01/19 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 89.74 on 10/25/24 | 56.20 on 10/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,874 | 171,526,160 | 121,597,008 | 111,439,232 | 110,128,096 |
| Shares Outstanding, K | 803 | 537,329 | 258,102 | 1,244,992 | 2,027,395 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -9,450,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | N/A | 8,388,000,000 | 2,645,600,000 | 6,954,000,000 | 12,201,000,000 |
| Last Quarter Net Income | N/A | 746,000,000 | -3,593,600,000 | 1,614,000,000 | 1,680,000,000 |
| 60-Month Beta | 1.17 | 0.60 | 0.39 | 0.17 | 0.44 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.58 on 10/30/24 | -12.83 on 08/01/24 | 2.01 on 08/08/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 05/23/18 | 10/30/24 | 11/04/24 | 11/06/24 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.770 on 09/13/24 | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 09/13/24 | 10/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.66 | 0.00 | 18.90 | 47.67 |